Offer - Urjas Oil for just ₹ 1 X
Tulixone 500 Mg Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Tulixone 500 Mg Injection safe for pregnant women?
There are no side effects of Tulixone in pregnant women.
Is the use of Tulixone 500 Mg Injection safe during breastfeeding?
Side effects of Tulixone on breastfeeding women are very mild.
What is the effect of Tulixone 500 Mg Injection on the Kidneys?
Tulixone rarely affects the kidneys.
What is the effect of Tulixone 500 Mg Injection on the Liver?
Very few cases of side effects of Tulixone on the liver have been reported.
What is the effect of Tulixone 500 Mg Injection on the Heart?
Using Tulixone does not have any harmful effects on the heart.
If you are suffering from any of the following diseases, you should not take Tulixone 500 Mg Injection unless your doctor advises you to do so -
Is this Tulixone 500 Mg Injection habit forming or addictive?
Tulixone 500 Mg Injection does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Tulixone 500 Mg Injection, you should not drive or work on any heavy machine, as Tulixone 500 Mg Injection can make you drowsy.
Is it safe?
Yes, but take Tulixone 500 Mg Injection only as per medical advice.
Is it able to treat mental disorders?
There is no benefit of taking Tulixone 500 Mg Injection for mental disorders.
Interaction between Food and Tulixone 500 Mg Injection
You can take Tulixone 500 Mg Injection with food.
Interaction between Alcohol and Tulixone 500 Mg Injection
Information about the interaction of Tulixone 500 Mg Injection and alcohol is not currently available because this topic has not been researched yet.
Do not self-administer Tulixone. It comes in the form of injection and preferably taken 1 - 2 times in a day (Intravenously or Intramuscularly). Take this medicine in the required quantity and duration as prescribed by your doctor. Discontinuing the a in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 14 days course even after getting symptomatic relief. In case you feel any discomfort such as breathing difficulties and skin reactions while taking this medicine please inform your doctor immediately.
Occasionally Tulixone can cause a drug to induce hemolytic anemia (abnormal Red blood cell breakdown). However, if your blood reports are showing abnormal hemolytic anemia after taking this drug please discuss with your doctor.
Tulixone does not help in preventing cold, because a common cold is a viral infection. However, the drug can help in bringing relief from symptoms of cold, if it is associated with a bacterial infection. To treat cold take ample rest, maintain proper hygiene, gargle with saline water and seek medical advice if common cold symptoms persist for more than 7-8 days.
Tulixone and doxycycline can be taken together, as there are no reported harmful interactions between them. However, it doesn't mean that no interactions exist between them. Please take if prescribed by a doctor.
Yes Tulixone is used to treat typhoid fever. It is a second-line treatment for typhoid fever. If other antibiotics are resistant to salmonella typhi then it is very effective to treat typhoid fever. However, it is best to consult your doctor about the right treatment for typhoid fever.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ceftriaxone
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 727-728
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 307-311